Supplemental material
Open access
2,469
Views
36
CrossRef citations to date
0
Altmetric
Research Paper
Anti-Helicobacter pylori activity of ethoxzolamide
Joyanta K. ModakDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia;
, Alexandra TikhomirovaDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia;
, Rebecca J. GorrellDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia; ;Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia;
, Mohammad M. RahmanDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia;
, Despina KotsanasMonash Infectious Diseases, Monash University, Monash Health, Australia;
, Tony M. KormanMonash Infectious Diseases, Monash University, Monash Health, Australia;
, Jose Garcia-BustosDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia;
, Terry KwokDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia; ;Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia;
, Richard L. FerreroCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Australia;
, Claudiu T. SupuranLaboratorio di Chimica Bioinorganica, Polo Scientifico, Università degli Studi di Firenze, Sesto Fiorentino, Italy; ;Neurofarba Department, Sezione di Scienze Farmaceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Italy
http://orcid.org/0000-0003-4262-0323
Anna RoujeinikovaDepartment of Microbiology, Monash University, Clayton, Australia; ;Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia; ;Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia; Correspondence[email protected]
show all
Pages 1660-1667
|
Received 24 Jul 2019, Accepted 23 Aug 2019, Published online: 17 Sep 2019
Related Research Data
In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori.
Source:
American Society for Microbiology
Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of β-class carbonic anhydrases from bacteria, fungi, and protozoa.
Source:
Informa UK Limited
Spontaneous Mutations That Confer Antibiotic Resistance in Helicobacter pylori
Source:
American Society for Microbiology
Relations among IOP reduction, ocular disposition and pharmacology of the carbonic anhydrase inhibitor ethoxzolamide
Source:
Elsevier BV
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study
Source:
Springer Science and Business Media LLC
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases.
Source:
Hindawi Limited
pH of the microclimate lining human gastric and duodenal mucosa in vivo: Studies in control subjects and in duodenal ulcer patients
Source:
Elsevier BV
Acid acclimation by Helicobacter pylori.
Source:
American Physiological Society
Building a comprehensive mill-level database for the Industrial Sectors Integrated Solutions (ISIS) model of the U.S. pulp and paper sector.
Source:
Public Library of Science (PLoS)
A Randomized, Controlled Study
Source:
American College of Physicians
Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Source:
American Chemical Society (ACS)
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Source:
Elsevier BV
Safety of carbonic anhydrase inhibitors
Source:
Informa Healthcare
Helicobacter pylori infection and the development of gastric cancer
Source:
Massachusetts Medical Society
Gastric Colonization by H. pylori
Source:
Springer Singapore
The α and β Classes Carbonic Anhydrases from Helicobacter pylori as Novel Drug Targets
Source:
Bentham Science Publishers Ltd.
The Helicobacter pylori mutY homologue HP0142 is an antimutator gene that prevents specific C to A transversions
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.